QQ客服 官方微博 反馈留言

	Tumor infiltrating CD19(+) B lymphocytes predict prognostic and therapeutic benefits in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors
	Lin, Zhiyuan; Liu, Li; Xia, Yu; Chen, Xiang; Xiong, Ying; Qu, Yang; Wang, Jiajun; Bai, Qi; Guo, Jianming; Xu, Jiejie
刊名	ONCOIMMUNOLOGY
	2018
卷号	7期号:10
关键词	tumor infiltrating B lymphocyte renal cell carcinoma tyrosine kinase inhibitor biomarkers survival
ISSN号	2162-402X
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3602689
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Lin, Zhiyuan,Liu, Li,Xia, Yu,et al. Tumor infiltrating CD19(+) B lymphocytes predict prognostic and therapeutic benefits in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors[J]. ONCOIMMUNOLOGY,2018,7(10).
APA	Lin, Zhiyuan.,Liu, Li.,Xia, Yu.,Chen, Xiang.,Xiong, Ying.,...&Xu, Jiejie.(2018).Tumor infiltrating CD19(+) B lymphocytes predict prognostic and therapeutic benefits in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors.ONCOIMMUNOLOGY,7(10).
MLA	Lin, Zhiyuan,et al."Tumor infiltrating CD19(+) B lymphocytes predict prognostic and therapeutic benefits in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors".ONCOIMMUNOLOGY 7.10(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。